Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Uncover ways to make extra money without spending and increase your savings. These strategies can help you boost your income effortlessly.
23,653 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
The SEC and CFTC announced a formal partnership to harmonize crypto regulation and pursue new digital asset products....
Hims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
A landmark revenue milestone meets a strategic investment push. This article breaks down why the billboard giant’s $1...
A Florida federal court dismissed CT Realtors, Smart MLS, and WeSERV from Zea’s lawsuit, signaling a narrower path fo...
Pi Network’s PI token fell about 30% within 24 hours after Kraken’s listing, renewing questions about the project’s r...
December 2025 is turning market expectations on their head. This update dives into unexpected seller strategies, shif...
Institutional buyers returned to digital assets in force, with BlackRock at the helm, buying roughly $600 million in ...
CoreWeave lands a major funding and strategic deals, reinforcing its AI GPU cloud niche, while investors weigh heavy ...
Bitcoin steadies near the top of its range as regulatory momentum builds. XRP, Pi Coin, and PEPE are flashing mixed s...
Investors are weighing CoreWeave against top AI stocks. This guide explains the risks, introduces three solid alterna...
The SEC has moved to clarify which crypto assets fall under securities rules, saying that many assets—including staki...